Evaluation of model‐based bioequivalence approach for single sample pharmacokinetic studies
CPT: Pharmacometrics & Systems Pharmacology · 2023-07 · 12 (7) · 904-915
DOI: 10.1002/psp4.12960 ↗Kurz gefasst
Fachartikel in der Zeitschrift CPT: Pharmacometrics & Systems Pharmacology, online erschienen am 27.04.2023. Verfasst von Coralie Tardivon und 10 weiteren Autor:innen. Beteiligte Einrichtung: INSERM, IAME, Université de Paris, Paris, France. Hauptthemen laut MEDLINE: Therapeutic Equivalency. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
In a traditional pharmacokinetic (PK) bioequivalence (BE) study, a two‐way crossover study is conducted, PK parameters (namely the area under the time‐concentration curve [AUC] and the maximal concentration []) are obtained by noncompartmental analysis (NCA), and the BE analysis is performed using the two one‐sided test (TOST) method. For ophthalmic drugs, however, only one sample of aqueous humor, in one eye, per eye can be obtained in each patient, which precludes the traditional BE analysis. To circumvent this issue, the U.S. Food and Drug Administration (FDA) has proposed an approach coupling NCA with either parametric or nonparametric bootstrap (NCA bootstrap). The model‐based TOST (MB‐TOST) has previously been proposed and evaluated successfully for various settings of sparse PK BE studies. In this paper, we evaluate, via simulations, MB‐TOST in the specific setting of single sample PK BE study and compare its performance to NCA bootstrap. We performed BE study simulations using a published PK model and parameter values and evaluated multiple scenarios, including study design (parallel or crossover), sampling times (5 or 10 spread across the dosing interval), and geometric mean ratio (of 0.8, 0.9, 1, and 1.25). Using the simulated structural PK model, MB‐TOST performed similarly to NCA bootstrap for AUC. For , the latter tended to be conservative and less powerful. Our research suggests that MB‐TOST may be considered as an alternative BE approach for single sample PK studies, provided that the PK model is correctly specified and the test drug has the same structural model as the reference drug.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- INSERM, IAME, Université de Paris, Paris, France.
- Département Epidémiologie Biostatistiques et Recherche Clinique, AP-HP, Hôpital Bichat, Paris, France.
- METRICS: Evaluation of Health Technologies and Medical Practices, University of Lille, CHU Lille, ULR 2694, Lille, France.
- Division of Quantitative Methods and Modeling, Office of Research Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, 20993, USA.
- Office of Biostatistics, Office of Translational Sciences, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, 20993, USA.
ORCID-Profile: Coralie Tardivon, Florence Loingeville, Mark Donnelly, Liang Zhao, France Mentré, Julie Bertrand
Zitieren
APA
Tardivon, C., Loingeville, F., Donnelly, M., Feng, K., Sun, W., Sun, G., Grosser, S., Zhao, L., Fang, L., Mentré, F., & Bertrand, J. (2023). Evaluation of model‐based bioequivalence approach for single sample pharmacokinetic studies. CPT: Pharmacometrics & Systems Pharmacology, 12(7), 904-915. https://doi.org/10.1002/psp4.12960
Vancouver
Tardivon C, Loingeville F, Donnelly M, Feng K, Sun W, Sun G, et al. Evaluation of model‐based bioequivalence approach for single sample pharmacokinetic studies. CPT: Pharmacometrics & Systems Pharmacology. 2023;12(7):904-915. doi:10.1002/psp4.12960
BibTeX
@article{Tardivon2023,
author = {Tardivon, Coralie and Loingeville, Florence and Donnelly, Mark and Feng, Kairui and Sun, Wanjie and Sun, Guoying and Grosser, Stella and Zhao, Liang and Fang, Lanyan and Mentré, France and Bertrand, Julie},
title = {Evaluation of model‐based bioequivalence approach for single sample pharmacokinetic studies},
journal = {CPT: Pharmacometrics & Systems Pharmacology},
year = {2023},
volume = {12},
number = {7},
pages = {904--915},
doi = {10.1002/psp4.12960}
}
EUVIMED